Glucotrack, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
GCTK$1.39-32.2%Stored close · as of Oct 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands of US Dollars)
| Three-month period ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (Unaudited) | ||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Loss for the period | $(4,334) | $(6,833) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 22 | 8 |
| Stock-based compensation | 61 | 40 |
| Amortization of original issue discount related to promissory note | 148 | - |
| Change in fair value of derivative liability | (1) | 3,376 |
| Amortization of debt discount and interest expense related to promissory notes | - | 3 |
| Changes in assets and liabilities: | ||
| Increase in other current assets | (1) | (204) |
| (Decrease) increase in accounts payable | (18) | 620 |
| Increase in other current liabilities | 75 | 51 |
| Net cash used in operating activities | (4,048) | (2,939) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of property and equipment | - | (9) |
| Net cash used in investing activities | - | (9) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Net proceeds from exercise of pre-funded warrants | 1 | - |
| Net proceeds from ELOC financing | 590 | - |
| Net proceeds from underwritten U.S. public offerings | - | 6,395 |
| Net cash provided by financing activities | 591 | 6,395 |
| Effect of exchange rate changes on cash and cash equivalents | 3 | 36 |
| Change in cash and cash equivalents | (3,454) | 3,483 |
| Cash and cash equivalents, at beginning of the period | 7,383 | 5,627 |
| Cash and cash equivalents, end of period | $3,929 | $9,110 |
| Three-month period ended March 31, | |||
|---|---|---|---|
| 2026 · 2025 | |||
| (Unaudited) | |||
| Supplemental disclosure of cash flow activities: | |||
| (a) Net cash paid during the quarter for: | |||
| Interest | $ | - | $28 |
| (b) Non-cash activities: | |||
| Recognition of right for usage asset against a lease liability | $ | - | $79 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.